‘Amazing’ trial shows drug combination stops lung cancer advancing for longer

“Better understanding of the biology that drives lung cancers has guided the development of these targeted therapies,” said Dr Martin Forster (UCL Research Department of Oncology) on his team’s newly developed treatment for lung cancer.

Read: Guardian